The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding (REASON-II)
The Dissemination of Consensus Recommendations on the Management of Canadian Patients With Non Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of a Multifaceted Tailored Implementation Strategy
Sponsor: Alberta Health services
Listed as NCT00840008, this PHASE4 trial focuses on Peptic Ulcer Hemorrhage and remains completed. Sponsored by Alberta Health services, it has been updated 13 times since 2008, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Study Description(click to expand)Clusters are randomized to receive a published algorithm and guidelines (control group), or a multifaceted, tailored educational intervention (see details in protocol - intervention group). The charts of treated patients with non variceal upper GI bleeding are reviewed and adherence to selected guidelines recorded.
Clusters are randomized to receive a published algorithm and guidelines (control group), or a multifaceted, tailored educational intervention (see details in protocol - intervention group). The charts of treated patients with non variceal upper GI bleeding are reviewed and adherence to selected guidelines recorded.
Status Flow
Change History
13 versions recorded-
Apr 2025 — Present [monthly]
Completed PHASE4
-
Mar 2025 — Apr 2025 [monthly]
Completed PHASE4
-
Sep 2024 — Mar 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Nov 2022 — Jul 2024 [monthly]
Completed PHASE4
▶ Show 8 earlier versions
-
Oct 2021 — Nov 2022 [monthly]
Completed PHASE4
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE4
-
Oct 2019 — Jan 2021 [monthly]
Completed PHASE4
-
Aug 2019 — Oct 2019 [monthly]
Completed PHASE4
-
May 2019 — Aug 2019 [monthly]
Completed PHASE4
-
Nov 2018 — May 2019 [monthly]
Completed PHASE4
-
Jun 2018 — Nov 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Sep 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alberta Health services
- CHAUQ - Hopital Saint Sacrement and Hopital Enfant Jesus
- CISSS de Chaudière-Appalaches
- Centre Hospitalier Anna Laberge
- Centre Hospitalier Pierre Boucher
- Centre hospitalier de l'Université de Montréal (CHUM)
- Cité de la Santé Hospital
- Foothills Medical Centre
- Grey Nuns Hospital
- Guelph General Hospital
- Hamilton Health Sciences Corporation
- Horizon Health Network
- Hotel Dieu Hospital
- Jewish General Hospital
- Kingston Health Sciences Centre
- Lakeridge Health Corporation
- London Health Sciences Centre
- Maisonneuve-Rosemont Hospital
- Matsqui-Sumas-Abbotsford General Hospital and Mission Memorial Hospital
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Misericordia
- Montreal General Hospital
- Peter Lougheed Centre
- Queen Elizabeth II Health Sciences Centre
- Regina General Hospital
- Royal Alexandra Hospital
- Royal University Hospital Foundation
- Royal Victoria Hospital, Canada
- Scarborough General Hospital
- St Mary's Hospital, London
- St-Johns Health Sciences Centre
- Sunnybrook Health Sciences Centre
- The Ottawa Hospital
- Toronto General Hospital
- Unity Health Toronto
- University of Alberta
- University of Manitoba
- Vancouver General Hospital
- York Central Hospital, Ontario
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.